Pharmacoepidemiology of psychotropic drugs: Examples of current research challenges on major public health issues

Epidemiologia e Psichiatria Sociale

Volumn 18, Issue 2, 2009, Pages 107-113

  Verdoux, Hélène ^a   Tournier, Marie ^a   Bégaud, Bernard ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

HUMAN; MEDICAL RESEARCH; PHARMACOEPIDEMIOLOGY; PUBLIC HEALTH; REVIEW;

BIOMEDICAL RESEARCH; HUMANS; PHARMACOEPIDEMIOLOGY; PSYCHOTROPIC DRUGS; PUBLIC HEALTH;

EID: 70449698756     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1121189x00000981     Document Type: Article

References (67)

1. Allard J., Artero S. & Ritchie K. (2003). Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. International Journal of Geriatric Psychiatry 18, 874-878. (Pubitemid 37294848)
2. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., de Girolamo G., Graaf R., Demyttenaere K., Gasquet I., Haro J.M., Katz S.J., Kessler R.C., Kovess V., Lepine J.P., Ormel J., Polidori G., Russo L.J., Vilagut G., Almansa J., ArbabzadehBouchez S., Autonell J., Bemal M., Buist-Bouwman M.A., Codony M., Domingo-Salvany A., Ferrer M., Joo S.S., Martinez-Alonso M., Matschinger H., Mazzi F., Morgan Z., Morosini P., Palacin C., Romera B., Taub N. & Vollebergh WA. (2004). Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, Suppl. 429, 55-64. (Pubitemid 38686197)
3. Aparasu R. R. & Bhatara V. (2005) Antipsychotic prescribing trends among youths, 1997-2002. Psychiatric Services 56, 904.
4. Aparasu R.R., Bhatara V. & Gupta S. (2005). U.S. national trends in the use of antipsychotics during office visits, 1998-2002. Annals of Clinical Psychiatry 17, 147-152. (Pubitemid 41176801)
5. Ashcroft. D.M., Frischer M., Lockert J. & Chapman S.R. (2002). Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiology Drug Safety 11, 285-289. (Pubitemid 34704728)
6. Barbui C. & Tansella M. (2005). Psychotropic drug epidemiology: the road travelled, the road ahead. International Review of Psychiatry 1.7, 143-151. (Pubitemid 40827291)
7. Barker M.J., Greenwood K.M., Jackson M. & Crowe S.F. (2004). Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Archives of Clinical Neuropsychology 19, 437-454. (Pubitemid 38373546)
8. Bauer M.S. & Mitchner L. (2004). What is a "mood stabilizer"? An evidence-based response. American Journal of Psychiatry 161, 3-18.
9. Bégaud B. (2000). Dictionary of Pharmacoepidemiology. John Wiley & Sons: Chichester.
10. Casper R., Fleisher B., Lee-Ancajas J., Gilles A., Gaylor E., DeBattista A. & Hoyme H. (2003). Follow-up of children of depressed mothers exposed or not exposed, to antidepressant drugs during pregnancy. Journal of Pediatrics 1.42, 402-408. (Pubitemid 36521227)
11. Chambers CD., Hernandez-Diaz S., Van Marter L. J, Werler M.M., Louik C., Jones K.L. & Mitchell A.A. (2006). Selective serotoninreuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New England Journal of Medicine 354, 579-587. (Pubitemid 43209105)
12. Clavelina A., Rossi. E., Derosa M. & Bonati M. (2007). Use of psychotropic medications in Italian children and adolescents. European Journal of Pediatrics 166, 339-347. (Pubitemid 46295091)
13. Cooper W.O., Hickson G.B., Fuchs C., Arbogast P.G. & Ray WA. (2004). New users of antipsychotic medications among children enrolled, in TennCare. Archives Pediatric Adolescent Medicine 158, 753-759. (Pubitemid 39025073)
14. Cooper W.O., Arbogast P.O., Din, H., Hickson G B., Fuchs D.C. & Ray WA. (2006). Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics 6, 79-83. (Pubitemid 43960577)
15. Cougnard A., Salmi L.R., Salamon R. & Verdoux H. (2005). A decision analysis model to assess the feasibility of the early detection of psychosis in the general population. Schizophrenia Research 74, 27-36. (Pubitemid 40203181)
16. De Las Cuevas C, de la Rosa M.A., Troyano J.M. & Sanz E.J. (2007). Are psychotropics drugs used in pregnancy? Pharmacoepidemiology Drug Safety 16, 1018-1023.
17. Dealberto M.J., McAvay G.J., Seeman T. & Berkman L. (1997). Psychotropic drug use and cognitive decline among older men and women. International Journal of Geriatric Psychiatry 12, 567-574. (Pubitemid 27239061)
18. Dewa C.S., Remington G., Herrmann N., Fearnley J. & Goering P. (2002). How much, are atypical antipsychotic agents being used, and do they reach, the populations who need them? A Canadian experience. Clinical Therapeutics 24, 1466-1476. (Pubitemid 35176978)
19. Fastbom J., Forsell Y. & Winblad B. (1998). Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Disease and Associated Disorders 12, 14-17. (Pubitemid 29108157)
20. Gagliardi J. & Krishnan K. (2003). Evidence-based mental health, use of anticonvulsants during pregnancy. Psyche-pharmacological Bulletin 37, 59-66.
21. Greenhill L.L., Vitiello B., Abikoff H., LevineJ., March. J.S., Riddle M.A., Capasso L., Cooper T.B., Davies M., Fisher P., Findling R.L., Fried J., Labellarte M.J., McCracken J.T., McMahon D., Robinson J., Skiobala A., Scahill L., Varipatis E., Walkup J.T. & Zito J.M. (2003a). Developing methodologies for monitoring long-term safety of psychotropic medications in. children: report on the NIMH conference, September 25, 2000. Journal of American Academic Child Adolescent Psychiatry 42, 651-655. (Pubitemid 39625050)
22. Greenhill L.L., Vitiello B., Riddle M.A., Fisher P., Shockey E., March J.S., Levine J., Fried J., Abikoff H., Zito J.M., McCracken J.T., Findling R.L., Robinson J., Cooper T.B., Davies M., Varipatis E., Labellarte M.J., Scahill L., Walkup J.T., Capasso L. & Rosengarten J. (2003b). Review of safety assessment methods used in pediatric psychopharmacology. Journal of American Academic Child Adolescent Psychiatry 42, 627-633. (Pubitemid 39625047)
23. Grolleau A., Cougnard A., Bégaud B. & Verdoux H. (2008). Psychotropic Drug Use and Correspondance with Psychiatric Diagnoses in the Mental Health in the General Population Survey. Encephale 34, 352-359.
24. Hanlon J.T., Horner R.D., Schmader K.E., Fillenbaum G.G., Lewis I.K., Wall W.E.Jr., Landerman L.R., Pieper L.R., Blazer D.O. & Cohen HJ. (1998). Benzodiazepine use and cognitive function among community-dwelling elderly. Clinical Pharmacology and Therapeutics 64, 684-692. (Pubitemid 29011388)
25. Healy D. (2006). The latest mania: selling bipolar disorder. PLOS Medicine 3, 441-444.
26. Hermann R.C., Yang D., Ettner S.L, Marcus S.C., Yoon C. & Abraham M. (2002). Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997. Psychiatric Services 53, 425-430.
27. Kaye J.A., Bradbury B.D. & Jick H. (2003). Changes in. antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. British Journal of Clinical Pharmacology 56, 569-575.
28. Lagnaoui R., Begaud B., Moore N., Chaslerie A., Fourrier A., Letenneur L., Dartigu.es J.F. & Moride Y. (2002). Benzodiazepine use and risk of dementia: a nested case-control study. Journal of Clinical Epidemiology 55, 314-318.
29. Lagnaoui R., Tournier M., Moride Y., Wolfson C., Ducruet T., Bégaud B. & Moore N. (2009). The risk of cognitive impairment in older community-dwelling women after benzodiazepine use. Age and Ageing 38, 226-229.
30. Linden M. & Thiel, C. (2001). Epidemiology of prescriptions for neuroleptic drugs: tranquilizers rather than antipsychotics. Pharmacopsychiatry 34, 150-154. (Pubitemid 32701766)
31. Lindesay J., Matthews R. & .Jagger C. (2003). Factors associated with antipsychotic drug use in. residential care: changes between. 1990 and. 1997. International Journal Geriatric Psychiatry 18, 511-519. (Pubitemid 36763654)
32. Martin A. & Leslie D. (2003). Trends in psychotropic medication costs for children and adolescents, 1997-2000. Archives Pediatric Adolescent Medicine 1.57, 997-1004.
33. Mirandola M., Andretta M., Corbari L., Sorio A., Nosé M. ́ Barbui C. (2006). Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002. Pharmacoepidemiology Drug Safety 15, 412-420.
34. Misri S., Reebye P., Kendrick K., Carter D., Ryan D., Grunau R.E. & Oberlander T.F. (2006). Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. American Journal of Psychiatry 163, 1026-1032. (Pubitemid 44464489)
35. Mond J., Morice R., Owen C. & Korten A. (2003) Use of antipsychotic medications in Australia between July 1995 and December 2001. Australian and New Zealand Journal of Psychiatry 37, 55-61. (Pubitemid 36395329)
36. Moynihan R., Heath L, Henry D. & Gtftzsche P. (2002). Selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal 324, 886-891. (Pubitemid 34303943)
37. Newport D. J., Brennan P.A., Green P., Ilardi D., Whitfield T.H., Morris N., Knight B.T. & Stowe Z.N. (2008). Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. British Journal of Obstetric and Gynecology 115, 681-688. (Pubitemid 351514588)
38. NICE (2006). Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. In Clinical Guideline No.38 (ed. National Institute for Health and Clinical Excellence).
39. Olfson M., Marcus S.C., Weissman M.M. & Jensen P.S. (2002). National trends in the use of psychotropic medications by children. Journal of American Academic Child Adolescent Psychiatry 41, 514-521. (Pubitemid 38338129)
40. Olfson. M., Blanco C., Liu L., Moreno C. & Laje G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 63, 679-685. (Pubitemid 43848299)
41. Patel N.C., Sanchez RJ., Johnsrud M.T. & Crismon M. L. (2002). Trends in antipsychotic use in a Texas medicaid population of children and adolescents: 1996 to 2000. Journal of Child Adolescent Psychopharmacology 12, 221-229.
42. Patel N.C., Crismon M.L., Hoagwood K., Johnsrud M.T., Rascati K.L., Wilson J.P. & Jensen RS. (2005). Trends in the use of typical, and atypical antipsychotics in children and adolescents. Journal of American Academic Child Adolescent Psychiatry 44, 548-556. (Pubitemid 40720954)
43. Paterniti S., Dufouil C. & Alperovitch A. (2002) Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. Journal of Clinical Psychopharmacology 22, 285-293. (Pubitemid 34546844)
44. Pelosi A. (2008). Is early intervention in the major psychiatric disorders justified? British Medical Journal 337, a710.
45. Percudani M., Barbui C., Fortino L., Tansella M. & Petrovich L. (2006). [Antidepressant and. antipsychotic drug prescribing in Lombardy]. Epidemiologia Psichiatria Sociale 15, 59-70.
46. Ramos E., Oraichi D., Rey R., Biais L. & Berard A. (2007). Prevalence and predictors of antidepressant use in a cohort of pregnant women. British Journal of Obstetric and Gynecology 114, 1055-1064. (Pubitemid 47247022)
47. Rapoport M., Mamdani M., Shulman K.I., Herrmann N. & Rochon P.A. (2005). Antipsychotic use in the elderly: shifting trends and increasing costs. International Journal of Geriatric Psychiatry 20, 749-753. (Pubitemid 41158720)
48. Ricciardi A., McAllister V. & Dazzan P. (2008). Is early intervention in psychosis effective? Epidemiologia e Psichiatria Sociale 17, 227235.
49. Santamaria B., Perez M., Montero D., Madurga M. & de Abajo F.J. (2002). Use of antipsychotic agents in Spain through 1985-2000. European Psychiatry 17, 471-476. (Pubitemid 36041858)
50. Schirm E., Tobi H., Zito J.M. & de Jong-van den Berg L.T. (2001). Psychotropic medication in children: a study from the Netherlands. Pediatrics 108, E25.
51. Schou M. (1976 ). What happened later to the lithium babies? A followup study of children born without malformations. Acta Psychiatrica Scandinavica 54, 193-197.
52. Sevilla-Dedieu C. & Kovess-Masfety V. (2008). Psychotropic medica- tion use in children and. adolescents: a study from France. Journal of Child Adolescent Psychopharmacology 18, 281-289.
53. Sorensen H.J., Mortensen E.L., Reinisch J.M. Sc Mednick S.A. (2003). Do hypertension and diuretic treatment in pregnancy increase the risk of schizophrenia in offspring? American Journal of Psychiatry 160, 464-468.
54. Sorensen H.J., Mortensen E.L., Reinisch J.M. Sc Mednick S.A. (2004). Association between prenatal exposure to analgesics and risk of schizophrenia. British Journal of Psychiatry 185, 366-371.
55. Trifiro G., Spina E., Brignoli O., Sessa E., Caputi A.P. & Mazzaglia G. (2005). Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. European Journal of Clinical Pharmacology 61, 47-53. (Pubitemid 40558279)
56. Verdoux H. (2004). Perinatal risk factors for schizophrenia: how specific are they? Current Psychiatry Report 6, 162-167.
57. Verdoux H. & Cougnard A. (2003). The early detection, and treatment controversy in schizophrenia research. Current Opinion in Psychiatry 16, 175-179. (Pubitemid 36288328)
58. Verdoux H., Gonzales B., T'akei N. & Bourgeois M. (1996). A survey of prescribing practice of antipsychotic maintenance treatment for manicdepressive outpatients. Journal of Affective Disorders 38, 81-87.
59. Verdoux H., Lagnaoui R. & Begaud B. (2005). Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychological Medicine 35, 307-315. (Pubitemid 40372470)
60. Verdoux H., Ropers J., Costagliola D., Clavel-Chapelon F. & Paoletti X. (2007). Serious psychiatric outcome of subjects prenatally exposed to diethylstilboestrol in the E3N cohort study. Psychological Medicine 37, 1315-1322. (Pubitemid 47244861)
61. Verdoux H., Toumier M. & Bégaud B. (submitted for publication). Antipsychotic prescribing trends: a literature review of pharmacoepidemiological studies.
62. Veronese A., Vivenza V., Nosè M., Cipriani A., Tansella M. Sc Barbui C. (2008) .Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach. Epidemiologia e Psichiatria Sociale 17, 236-241.
63. Wakschlag L.S., Pickett K.E., Cook E.,Jr., Benowitz N.L & Leventhal B.L. (2002). Maternal smoking during pregnancy and severe antisocial behavior in offspring: a review. American Journal of Public Health 92, 966-974. (Pubitemid 34552901)
64. Wong I. C., Camilleri-Novak D. & Stephens P. (2003) Rise in psychotropic drug prescribing in children in the UK: an urgent public health issue. Drug Safety 26, 1117-1118. (Pubitemid 38021392)
65. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S.V., MacQueen G., Mclntyre R.S., Sharma V. & Beaulieu S. (2006). Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorder 8, 721-739.
66. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M. & Lynch F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association 283, 1025-1030.
67. Zito J.M., Safer D.J., DosReis S., Gardner J.F., Magder L., Soeken K., Boles M., Lynch F. & Riddle MA. (2003). Psychotropic practice patterns for youth: a 10-year perspective. Archives Pediatric Adolescent Medicine 157, 17-25. (Pubitemid 36343413)